Quality indicators in the intensity modulated/image-guided radiotherapy era

Published on Dec 1, 2016in Critical Reviews in Oncology Hematology5.833
· DOI :10.1016/J.CRITREVONC.2016.10.013
Pietro Gabriele23
Estimated H-index: 23
Angelo Maggio11
Estimated H-index: 11
+ 8 AuthorsMichele Stasi27
Estimated H-index: 27
Abstract Purpose To propose new Quality Indicators (QIs) for the Intensity Modulated(IMRT)/Image-Guided(IGRT) Radiotherapy techniques. Materials and methods Two structure, 10 process and 2 outcome QIs were elaborated. A working group including Radiation Oncologist, Medical Physicist and Radiation Technologists was made up. A preliminary set of indicators was selected on the basis of evidenced critical issues; the criteria to identify more relevant and specific QIs for IMRT/IGRT were defined; structure, process and outcome QIs were defined. The elaborated indicators were tested in four Italian Radiotherapy Centers. Results Fourteen indicators were proposed. Seven indicators were completely new while a new standard is proposed for four indicators based on Validation Centers (VC) data. No change was reported for 3 indicators. The indicators were applied in the four VC. The VC considered were able to respect all indicators except indicator 2 for one Center. Discussion and conclusion QIs may provide useful measures of workload and service performances.
📖 Papers frequently viewed together
9 Citations
6 Citations
48 Citations
#1Stéphane Supiot (University of Nantes)H-Index: 29
#2Emmanuel RioH-Index: 17
Last. F PeinH-Index: 15
view all 6 authors...
Background Metastatic prostate cancer remains a common cause of death in Europe, and improvements in management of the disease are urgently needed. The advent of positron-emission tomography (PET) imaging enhanced with fluorocholine has led to the identification of a new sub-group of metastatic prostate cancer patients: those with so-called oligometastatic disease. Presenting with a low burden of metastatic disease (≤5 lesions), this new sub-group lies between true metastatic prostate cancer pat...
38 CitationsSource
#1Marie Tvilum (Aarhus University Hospital)H-Index: 2
#2Azza A. Khalil (Aarhus University Hospital)H-Index: 18
Last. Marianne Marquard Knap (Aarhus University Hospital)H-Index: 15
view all 5 authors...
ABSTRACTBackground. Adaptive strategy with daily online tumour match is a treatment option when treating locally advanced lung cancer patients with curative intended radiotherapy (RT).Material and methods. Fifty-two consecutive lung cancer patients treated with soft tissue match, adaptive RT and small planning target volumes (PTV) margins were analysed. A control group of 52 consecutive patients treated with bone match, no adaptive strategy and larger margins was included. Patients were followed...
30 CitationsSource
#1Charlotte L. Brouwer (UMCG: University Medical Center Groningen)H-Index: 14
#2Roel J.H.M. Steenbakkers (UMCG: University Medical Center Groningen)H-Index: 28
Last. Nanna M. Sijtsema (UMCG: University Medical Center Groningen)H-Index: 22
view all 4 authors...
Abstract In the last decade, many efforts have been made to characterize anatomic changes of head and neck organs at risk (OARs) and the dosimetric consequences during radiotherapy. This review was undertaken to provide an overview of the magnitude and frequency of these effects, and to investigate whether we could find criteria to identify head and neck cancer patients who may benefit from adaptive radiotherapy (ART). Possible relationships between anatomic and dosimetric changes and outcome we...
95 CitationsSource
#1Ze-Tian Shen (NU: Nanjing University)H-Index: 5
#2Xin-Hu Wu (NU: Nanjing University)H-Index: 6
Last. Xi-Xu Zhu (NU: Nanjing University)H-Index: 5
view all 4 authors...
The aim of this study was to evaluate the clinical outcome of CyberKnife stereotactic body radiotherapy (SBRT) for patients with stage I non-small cell lung cancer (NSCLC). Fifty patients with peripheral stage I NSCLC who refused surgery or were medically inoperable were treated with 48–60 Gy (median dose: 57 Gy) in three divided doses. Histopathology was available in 86 % of patients. Thirty patients had a T1 tumor, and 20 patients had T2 tumors. More than 95 % of the target volume was covered ...
14 CitationsSource
Background: Positive para-aortic lymph node (PALN) at diagnosis in cervical cancer patients confers an unfavorable prognosis. This study reviewed the outcomes of extended field radiotherapy (EFRT) and concurrent chemotherapy with extended field RT (CCEFRT) in patients with positive PALN at diagnosis. Materials and Methods: Medical records of 407 cervical cancer patients between 1st January 2002 to 31st December 2012 were reviewed. Some 32 cases with positive PALN were identified to have received...
2 CitationsSource
#1Maria Aggeliki Kalogeridi (RMIT: RMIT University)H-Index: 1
#2George Kyrgias (RMIT: RMIT University)H-Index: 10
Last. Vassilios Kouloulias (UoA: National and Kapodistrian University of Athens)H-Index: 20
view all 7 authors...
In the last decades the status of radiotherapy was tremendously increased in terms of conformity to the target as well as image-guided techniques in conjunction with intensity-modulated radiotherapy (IMRT). The technological improvement had a significant clinical outcome for better response and lower toxicity to the surrounding normal tissues. Nowadays the incidence of rectal toxicity has been significantly decreased, especially with image guided radi­ation therapy (IGRT), whereas the dose escal...
5 CitationsSource
#1Wim J.G. Oyen (Radboud University Nijmegen)H-Index: 110
Imaging for radiotherapy is indicated during all phases of diagnosis and treatment: for staging, radiotherapy planning, therapy response monitoring and prediction, follow-up and relapse detection. Besides conventional CT imaging, functional (e.g. MRI) and molecular (e.g. PET) imaging modalities are increasingly used in patients before, during and after radiotherapy.
1 CitationsSource
#1Peter Dunscombe (U of C: University of Calgary)H-Index: 22
#2Cai Grau (Aarhus University Hospital)H-Index: 60
Last. Yolande Lievens (Ghent University Hospital)H-Index: 23
view all 10 authors...
Abstract Background and purpose In planning to meet evidence based needs for radiotherapy, guidelines for the provision of capital and human resources are central if access, quality and safety are not to be compromised. A component of the ESTRO-HERO (Health Economics in Radiation Oncology) project is to document the current availability and content of guidelines for radiotherapy in Europe. Materials and methods An 84 part questionnaire was distributed to the European countries through their nati...
51 CitationsSource
#1Yolande Lievens (Ghent University Hospital)H-Index: 29
#2Mary Coffey (Trinity College, Dublin)H-Index: 15
Last. Cai Grau (Aarhus University Hospital)H-Index: 60
view all 10 authors...
Background: The ESTRO Health Economics in Radiation Oncology (HERO) project has the overall aim to develop a knowledge base of the provision of radiotherapy in Europe and build a model for health economic evaluation of radiation treatments at the European level. The first milestone was to assess the availability of radiotherapy resources within Europe. This paper presents the personnel data collected in the ESTRO HERO database. Materials and methods: An 84-item questionnaire was sent out to Euro...
66 CitationsSource
#1Jinhong Jung (Kyung Hee University)H-Index: 11
#2Geumju Park (UOU: University of Ulsan)H-Index: 4
Last. Young Seok Kim (UOU: University of Ulsan)H-Index: 18
view all 3 authors...
AIM: To evaluate the efficacy and toxicity of definitive extended-field intensity-modulated radiotherapy (EF-IMRT) with chemotherapy in cervical cancer with para-aortic lymph node (PAN) metastasis. PATIENTS AND METHODS: The present retrospective cohort study involved 45 consecutive patients. EF-IMRT consisted of 46 Gy to pelvic and para-aortic regions, 14 Gy-boost to gross nodes, and 30 Gy in six fractions of intracavitary brachytherapy. Platinum-based chemotherapy occurred simultaneously. RESUL...
10 Citations
Cited By5
#1Ajay Aggarwal (Lond: University of London)H-Index: 18
#2Julie Nossiter (RCS: Royal College of Surgeons of England)H-Index: 8
Last. Jan van der Meulen (RCS: Royal College of Surgeons of England)H-Index: 61
view all 8 authors...
The public reporting of patient outcomes is crucial for quality improvement and informing patient choice. However, outcome reporting in radiotherapy, despite being a major component of cancer control, is extremely sparse globally. Public reporting has many challenges, including difficulties in defining meaningful measures of treatment quality, limitations in data infrastructure, and fragmented health insurance schemes. The National Prostate Cancer Audit (NPCA), done in the England and Wales Nati...
1 CitationsSource
#1A. Di DiaH-Index: 2
#2Angelo MaggioH-Index: 11
Last. Pietro GabrieleH-Index: 23
view all 14 authors...
AIM: Nowadays, no Quality Indicators (QI) have been proposed for Hyperthermia treatments. Starting from radiotherapy experience, the aim of this work is to adapt radiotherapy indicators to Hyperthermia and to propose a new specific set of QI in Hyperthermia field. MATERIAL AND METHODS: At first, radiotherapy quality indicators published in literature have been adapted to hyperthermia setting. Moreover, new specific indicators for the treatment of hyperthermia have been defined. To obtain the sta...
1 CitationsSource
This study investigates the quality indicators (QIs) of medical care that are expected to be introduced to radiotherapy departments in Japan and evaluates whether the QIs reflect the characteristics of the treatment facilities. For this purpose, a questionnaire survey was administered to radiotherapy treatment facilities in Japan. A consensus of early QI candidates was obtained from the panel members. The characteristics identified in the candidate QIs were subdivided into 140 items covering 27 ...
#1a. Andrea gallaH-Index: 1
#2Angelo MaggioH-Index: 11
Last. Domenico Gabriele (University of Sassari)H-Index: 5
view all 9 authors...
BACKGROUND: To evaluate the outcome of patients treated with salvage radiotherapy after radical prostatectomy and to investigate the effects of independent predictors on survival. METHODS: From January 2000 to December 2015, 234 patients with biochemical/clinical recurrences after radical prostatectomy were submitted to salvage radiotherapy (SRT). One hundred and fifty-seven patients (67%) received three-dimensional (3D) conformal radiotherapy while 77 patients (33%) were treated with intensity-...
1 CitationsSource
#1Aude VaanderingH-Index: 2
#2Nuria JornetH-Index: 16
Last. Yolande LievensH-Index: 23
view all 5 authors...
2 CitationsSource